Trials
Search / Trial NCT05647876

A Longitudinal Study to Identify Mechanisms of Menopause on Cardiovascular Disease Risk

Launched by UNIVERSITY OF COPENHAGEN · Dec 3, 2022

Trial Information

Current as of February 05, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how menopause affects women's heart health over time. After menopause, the body stops producing estrogen, which can lead to a higher risk of heart problems such as hardening of the arteries, heart attacks, and strokes. The researchers will follow 200 women from before they enter menopause and for at least 10 years afterward. They will look closely at changes in the blood vessels, heart, and brain, and analyze blood samples to understand better how menopause influences cardiovascular health.

To be eligible for this study, women should have a normal heart test and regular menstrual cycles. However, there are some exclusions, such as those who smoke, are on hormone therapy, have certain chronic diseases, or are pregnant or breastfeeding. Participants can expect regular check-ups and tests to monitor their health throughout the study. This research aims to provide valuable insights into the connection between menopause and heart disease, which could help improve health strategies for women as they age.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Normal ECG
  • Regular menstruation
  • Exclusion Criteria:
  • Participation in other clinical projects
  • Smokes or has smoked within the last 10 years
  • On hormone therapy
  • Has chronic diseases that are not expected, cf. the groups sought. Including heart problems, atrial fibrillation, cancer, immune diseases and previous strokes with functionally significant sequelae
  • Being treated with oral steroids
  • Has alcohol / drug abuse or is being treated with disulfiram (Antabus)
  • Is unable to understand the contents of the document with informed consent or the experimental procedures
  • Pregnancy or breastfeeding
  • Systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg
  • ovariectomy
  • BMI\>28

Trial Officials

Lasse Gliemann, PhD

Principal Investigator

Department of Nutrition, Exercise and Sports, University of Copenhagen, 2200 Copenhagen, Denmark

About University Of Copenhagen

The University of Copenhagen, a leading research institution in Denmark, is dedicated to advancing medical knowledge and improving patient outcomes through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its expertise in various fields, including health sciences, pharmacology, and biotechnology, to design and conduct rigorous clinical studies. Committed to ethical standards and scientific integrity, the University of Copenhagen aims to contribute significantly to the global medical community by facilitating groundbreaking research that addresses pressing healthcare challenges.

Locations

Copenhagen, , Denmark

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials